US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VivoSim Lab, Inc.

0.2823

-0.0037-1.29%

Volume:67.32K

Turnover:18.96K

Market Cap:4.19M

PE:-0.06

High:0.2840

Open:0.2840

Low:0.2806

Close:0.2860

52wk High:5.30

52wk Low:0.2625

Shares:14.85M

Float Shares:14.54M

Volume Ratio:1.56

T/O Rate:0.46%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.4600

EPS(LYR):-1.6999

ROE:-343.10%

ROA:-89.50%

PB:-1.79

PE(LYR):-0.17

Loading ...

Overview Company News Filings

Vivosim Forecasts Fy2027 Revenue Growth of 500%+

Vivosim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That it Expects Revenue Growth of 500%+ in Fy2027

THOMSON REUTERS

Vivosim Labs - Eligible for up to $45 Mln in Additional Milestone Payments from Eli Lilly

THOMSON REUTERS

VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027

Vivosim Labs FY26 Other Income Swings to USD 2.35 Million Expense; Revenue Rises 10% to USD 131,000

Vivosim Labs Delays Annual Report Filing, Targets July 14 Release

Vivosim Reports >90% Sensitivity in Liver Toxicity Prediction Study at ESTIV 2026

Top News Today: Stocks Mixed Amid Tech Weakness, Oil Slide

VivoSim AI model predicts drug diarrhea risk with 96% accuracy using human intestinal tissues

VivoSim prices up to $4 million best-efforts public offering at $1.14 a share

BRIEF-Vivosim Announces Pricing Of Up To A $4 Million Public Offering

VivoSim Labs prices up to $4 million best-efforts public offering

Vivosim Announces Pricing of up to a $4 Million Public Offering

THOMSON REUTERS

VivoSim validates NAMkind liver and intestine models for predicting ADC toxicity profiles

VivoSim appoints Arumugham Raghunathan as VP, global sales

BRIEF-Vivosim Appoints Arumugham (Ragoo) Raghunathan As Vice President Of Global Sales

VivoSim Labs Names Arumugham Raghunathan VP of Global Sales

Vivosim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales

THOMSON REUTERS

Press Release: VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/VIVS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VIVS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VIVS\",,,,,undefined,":{"symbol":"VIVS","market":"US","secType":"STK","nameCN":"VivoSim Lab, Inc.","latestPrice":0.2823,"timestamp":1787578812178,"preClose":0.286,"halted":0,"volume":67315,"delay":0,"changeRate":-0.012937062937062873,"floatShares":14535000,"shares":14850600,"eps":-4.46,"marketStatus":"Trading","change":-0.0037,"latestTime":"08-24 09:42:12 EDT","open":0.284,"high":0.284,"low":0.2806,"amount":18961.275737,"amplitude":0.011888,"askPrice":0.2838,"askSize":500,"bidPrice":0.2805,"bidSize":2136,"shortable":3,"etf":0,"ttmEps":-4.46,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"listingDate":1373515200000,"exchange":"NASDAQ","adjPreClose":0.286,"preHourTrading":{"tag":"盘前","latestPrice":0.2836,"preClose":0.286,"latestTime":"09:25 EDT","volume":40942,"amount":11690.537737999999,"timestamp":1787577956907,"change":-0.0024,"changeRate":-0.008392,"amplitude":0.062238},"postHourTrading":{"tag":"盘后","latestPrice":0.2737,"preClose":0.286,"latestTime":"19:59 EDT","volume":88518,"amount":24816.239999,"timestamp":1787356791234,"change":-0.0123,"changeRate":-0.043007,"amplitude":0.043007},"volumeRatio":1.562633},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VIVS\",,,,,undefined,":{"symbol":"VIVS","floatShares":14535000,"roa":"-89.50%","roe":"-343.10%","lyrEps":-1.699907,"volumeRatio":1.562633,"shares":14850600,"dividePrice":0,"high":0.284,"amplitude":0.011888,"preClose":0.286,"low":0.2806,"week52Low":0.2625,"pbRate":"-1.79","psRate":"37.43","week52High":5.3,"institutionHeld":0,"latestPrice":0.2823,"committee":0.620637,"eps":-4.46,"divideRate":0,"volume":67315,"delay":0,"ttmEps":-4.46,"open":0.284,"prevYearClose":1.81,"prevWeekClose":0.286,"prevMonthClose":0.3446,"prevQuarterClose":1.07,"fiveDayClose":0.318,"twentyDayClose":0.3898,"sixtyDayClose":1.31},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VIVS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"VIVS","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2026-07-14","symbol":"VIVS","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1784001600000,"reportTimeType":"post","actualEps":-2.21},{"date":"2026-02-11","symbol":"VIVS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770843600000,"name":null,"time":"Post-Mkt","dateTimestamp":1770786000000,"actualEps":null},{"market":"US","date":"2025-11-06","symbol":"VIVS","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.98},{"market":"US","date":"2025-08-12","symbol":"VIVS","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-1.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VIVS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VIVS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VIVS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VIVS","date":"2026-08-21","current":-0.064126,"percent":0.872987,"low":-6.25416,"twenty":-3.066727,"median":-1.002727,"eighty":-0.451589,"high":-0.083269,"avg":-1.731924,"sd":1.393057,"marketCap":4121044},"quantilePoints":[{"date":"2024-05-31","current":-0.963147,"twenty":-0.792497,"median":-0.671162,"eighty":-0.661504,"marketCap":14130334},{"date":"2024-06-07","current":-0.940616,"twenty":-0.974746,"median":-0.940616,"eighty":-0.672676,"marketCap":13799784},{"date":"2024-06-14","current":-0.887326,"twenty":-0.967771,"median":-0.932486,"eighty":-0.803888,"marketCap":13017959},{"date":"2024-06-21","current":-0.791912,"twenty":-0.954135,"median":-0.915735,"eighty":-0.804294,"marketCap":11618147},{"date":"2024-06-28","current":-0.746557,"twenty":-0.940538,"median":-0.887326,"eighty":-0.743853,"marketCap":10952734},{"date":"2024-07-05","current":-0.737642,"twenty":-0.939205,"median":-0.822868,"eighty":-0.738524,"marketCap":10821950},{"date":"2024-07-12","current":-0.664172,"twenty":-0.933602,"median":-0.76174,"eighty":-0.706099,"marketCap":9744067},{"date":"2024-07-19","current":-0.578946,"twenty":-0.930565,"median":-0.746557,"eighty":-0.664172,"marketCap":8493722},{"date":"2024-07-26","current":-0.577379,"twenty":-0.924492,"median":-0.739847,"eighty":-0.617558,"marketCap":8470727},{"date":"2024-08-02","current":-0.535844,"twenty":-0.899473,"median":-0.734703,"eighty":-0.576281,"marketCap":7861363},{"date":"2024-08-09","current":-0.601951,"twenty":-0.891715,"median":-0.702866,"eighty":-0.577692,"marketCap":8419492},{"date":"2024-08-16","current":-0.621174,"twenty":-0.879352,"median":-0.664172,"eighty":-0.581087,"marketCap":8688362},{"date":"2024-08-23","current":-0.67969,"twenty":-0.842538,"median":-0.663883,"eighty":-0.589715,"marketCap":9506820},{"date":"2024-08-30","current":-0.637102,"twenty":-0.816677,"median":-0.663684,"eighty":-0.590571,"marketCap":8911141},{"date":"2024-09-06","current":-0.59536,"twenty":-0.791912,"median":-0.660499,"eighty":-0.592944,"marketCap":8327307},{"date":"2024-09-13","current":-0.59536,"twenty":-0.773888,"median":-0.655973,"eighty":-0.589978,"marketCap":8327307},{"date":"2024-09-20","current":-0.545271,"twenty":-0.749593,"median":-0.637102,"eighty":-0.577379,"marketCap":7626708},{"date":"2024-09-27","current":-0.511659,"twenty":-0.748369,"median":-0.626667,"eighty":-0.572293,"marketCap":7156568},{"date":"2024-10-04","current":-0.511878,"twenty":-0.746557,"median":-0.620625,"eighty":-0.568073,"marketCap":7159641},{"date":"2024-10-11","current":-0.491063,"twenty":-0.74401,"median":-0.615133,"eighty":-0.556415,"marketCap":6868502},{"date":"2024-10-18","current":-0.516331,"twenty":-0.742051,"median":-0.606345,"eighty":-0.545271,"marketCap":7221915},{"date":"2024-10-25","current":-0.485461,"twenty":-0.737642,"median":-0.603083,"eighty":-0.521764,"marketCap":6790137},{"date":"2024-11-01","current":-0.510838,"twenty":-0.734703,"median":-0.601951,"eighty":-0.513636,"marketCap":7145086},{"date":"2024-11-08","current":-0.492018,"twenty":-0.734703,"median":-0.59536,"eighty":-0.510508,"marketCap":6170895},{"date":"2024-11-15","current":-0.511988,"twenty":-0.709234,"median":-0.589978,"eighty":-0.505947,"marketCap":6421358},{"date":"2024-11-22","current":-0.490058,"twenty":-0.705315,"median":-0.581661,"eighty":-0.496886,"marketCap":6146310},{"date":"2024-11-29","current":-0.582557,"twenty":-0.701397,"median":-0.578162,"eighty":-0.496886,"marketCap":7306427},{"date":"2024-12-06","current":-0.562342,"twenty":-0.689309,"median":-0.577379,"eighty":-0.501808,"marketCap":7052891},{"date":"2024-12-13","current":-0.495694,"twenty":-0.681058,"median":-0.57573,"eighty":-0.499264,"marketCap":6216992},{"date":"2024-12-20","current":-0.441052,"twenty":-0.6791,"median":-0.572293,"eighty":-0.49526,"marketCap":5531679},{"date":"2024-12-27","current":-0.449628,"twenty":-0.678819,"median":-0.571195,"eighty":-0.490661,"marketCap":5639239},{"date":"2025-01-03","current":-0.556829,"twenty":-0.672907,"median":-0.568073,"eighty":-0.49046,"marketCap":6983745},{"date":"2025-01-10","current":-0.490181,"twenty":-0.664172,"median":-0.568073,"eighty":-0.490357,"marketCap":6147846},{"date":"2025-01-17","current":-0.474131,"twenty":-0.664074,"median":-0.562171,"eighty":-0.487102,"marketCap":5946555},{"date":"2025-01-24","current":-0.419,"twenty":-0.663684,"median":-0.558014,"eighty":-0.485461,"marketCap":5255095},{"date":"2025-01-31","current":-0.44289,"twenty":-0.663594,"median":-0.556415,"eighty":-0.474131,"marketCap":5554727},{"date":"2025-02-07","current":-0.428556,"twenty":-0.660499,"median":-0.551293,"eighty":-0.468872,"marketCap":5374948},{"date":"2025-02-14","current":-0.472906,"twenty":-0.659274,"median":-0.546415,"eighty":-0.461402,"marketCap":5931189},{"date":"2025-02-21","current":-0.520039,"twenty":-0.658549,"median":-0.542249,"eighty":-0.462764,"marketCap":6440682},{"date":"2025-02-28","current":-0.916058,"twenty":-0.663612,"median":-0.545843,"eighty":-0.465065,"marketCap":11345377},{"date":"2025-03-07","current":-0.742992,"twenty":-0.678775,"median":-0.54911,"eighty":-0.466535,"marketCap":9201960},{"date":"2025-03-14","current":-0.699132,"twenty":-0.681058,"median":-0.554946,"eighty":-0.468454,"marketCap":8658746},{"date":"2025-03-21","current":-0.452132,"twenty":-0.681058,"median":-0.553477,"eighty":-0.468454,"marketCap":5599653},{"date":"2025-03-28","current":-0.347018,"twenty":-0.6791,"median":-0.548844,"eighty":-0.460321,"marketCap":4297822},{"date":"2025-04-04","current":-0.305261,"twenty":-0.678775,"median":-0.545271,"eighty":-0.448893,"marketCap":3780657},{"date":"2025-04-11","current":-0.239745,"twenty":-0.676584,"median":-0.537699,"eighty":-0.442253,"marketCap":2969242},{"date":"2025-04-17","current":-0.247665,"twenty":-0.670012,"median":-0.532652,"eighty":-0.441052,"marketCap":3067325},{"date":"2025-04-25","current":-0.267823,"twenty":-0.664899,"median":-0.528415,"eighty":-0.439043,"marketCap":3316991},{"date":"2025-05-02","current":-0.287982,"twenty":-0.664172,"median":-0.524922,"eighty":-0.433701,"marketCap":3566658},{"date":"2025-05-09","current":-0.273583,"twenty":-0.663879,"median":-0.520039,"eighty":-0.428874,"marketCap":3388325},{"date":"2025-05-16","current":-0.298061,"twenty":-0.66363,"median":-0.518608,"eighty":-0.426522,"marketCap":3691491},{"date":"2025-05-23","current":-0.287982,"twenty":-0.663349,"median":-0.515786,"eighty":-0.420029,"marketCap":3566658},{"date":"2025-05-30","current":-0.268385,"twenty":-0.662111,"median":-0.513636,"eighty":-0.417726,"marketCap":3323946},{"date":"2025-06-06","current":-1.315277,"twenty":-0.662111,"median":-0.511933,"eighty":-0.415594,"marketCap":3272408},{"date":"2025-06-13","current":-1.807734,"twenty":-0.664172,"median":-0.514439,"eighty":-0.416647,"marketCap":4497643},{"date":"2025-06-20","current":-1.47346,"twenty":-0.678193,"median":-0.516331,"eighty":-0.416941,"marketCap":3665969},{"date":"2025-06-27","current":-1.483805,"twenty":-0.696612,"median":-0.519913,"eighty":-0.417628,"marketCap":3691707},{"date":"2025-07-03","current":-1.640545,"twenty":-0.705315,"median":-0.520902,"eighty":-0.41802,"marketCap":4081676},{"date":"2025-07-11","current":-2.058518,"twenty":-0.734703,"median":-0.526707,"eighty":-0.418755,"marketCap":5121594},{"date":"2025-07-18","current":-1.943576,"twenty":-0.742992,"median":-0.528748,"eighty":-0.419,"marketCap":4835616},{"date":"2025-07-25","current":-2.309302,"twenty":-0.749593,"median":-0.533991,"eighty":-0.420715,"marketCap":5745544},{"date":"2025-08-01","current":-1.954025,"twenty":-0.822868,"median":-0.540901,"eighty":-0.424268,"marketCap":4861614},{"date":"2025-08-08","current":-1.825498,"twenty":-0.887326,"median":-0.546415,"eighty":-0.424758,"marketCap":4541840},{"date":"2025-08-15","current":-2.355123,"twenty":-0.916058,"median":-0.551293,"eighty":-0.425125,"marketCap":4679629},{"date":"2025-08-22","current":-2.590635,"twenty":-0.94042,"median":-0.556415,"eighty":-0.427453,"marketCap":5147592},{"date":"2025-08-29","current":-2.446711,"twenty":-0.974805,"median":-0.558014,"eighty":-0.428556,"marketCap":4861614},{"date":"2025-09-05","current":-2.956987,"twenty":-1.221393,"median":-0.562171,"eighty":-0.428654,"marketCap":5875534},{"date":"2025-09-12","current":-4.834544,"twenty":-1.517243,"median":-0.568073,"eighty":-0.428776,"marketCap":9606238},{"date":"2025-09-19","current":-5.142018,"twenty":-1.544411,"median":-0.571195,"eighty":-0.428899,"marketCap":10217190},{"date":"2025-09-26","current":-4.513985,"twenty":-1.617556,"median":-0.57395,"eighty":-0.430211,"marketCap":8969289},{"date":"2025-10-03","current":-4.527069,"twenty":-1.745638,"median":-0.575974,"eighty":-0.433067,"marketCap":8995287},{"date":"2025-10-10","current":-4.350435,"twenty":-1.830305,"median":-0.578946,"eighty":-0.433701,"marketCap":8644315},{"date":"2025-10-17","current":-3.414928,"twenty":-1.87461,"median":-0.587012,"eighty":-0.433701,"marketCap":6785462},{"date":"2025-10-24","current":-2.878483,"twenty":-1.918497,"median":-0.592944,"eighty":-0.434682,"marketCap":5719546},{"date":"2025-10-31","current":-3.899037,"twenty":-1.958205,"median":-0.596003,"eighty":-0.436887,"marketCap":7747386},{"date":"2025-11-07","current":-2.865399,"twenty":-2.01879,"median":-0.600199,"eighty":-0.437769,"marketCap":5693548},{"date":"2025-11-14","current":-2.814442,"twenty":-2.071058,"median":-0.601951,"eighty":-0.439435,"marketCap":5581038},{"date":"2025-11-21","current":-2.853897,"twenty":-2.297704,"median":-0.603709,"eighty":-0.440807,"marketCap":5659277},{"date":"2025-11-28","current":-2.945958,"twenty":-2.315871,"median":-0.605099,"eighty":-0.441052,"marketCap":5841834},{"date":"2025-12-05","current":-3.011716,"twenty":-2.360357,"median":-0.610146,"eighty":-0.441052,"marketCap":5972232},{"date":"2025-12-12","current":-2.972261,"twenty":-2.438233,"median":-0.617439,"eighty":-0.441052,"marketCap":5893994},{"date":"2025-12-19","current":-2.538258,"twenty":-2.548779,"median":-0.623646,"eighty":-0.441331,"marketCap":5033366},{"date":"2025-12-26","current":-2.735532,"twenty":-2.604016,"median":-0.629412,"eighty":-0.441772,"marketCap":5424560},{"date":"2026-01-02","current":-2.380439,"twenty":-2.604016,"median":-0.639463,"eighty":-0.442179,"marketCap":4720411},{"date":"2026-01-09","current":-2.735532,"twenty":-2.63781,"median":-0.658368,"eighty":-0.442375,"marketCap":5424560},{"date":"2026-01-16","current":-2.643603,"twenty":-2.643471,"median":-0.661843,"eighty":-0.442792,"marketCap":5242264},{"date":"2026-01-23","current":-2.63032,"twenty":-2.643603,"median":-0.663639,"eighty":-0.44289,"marketCap":5215924},{"date":"2026-01-30","current":-2.235772,"twenty":-2.643471,"median":-0.664172,"eighty":-0.445953,"marketCap":4433535},{"date":"2026-02-06","current":-3.406264,"twenty":-2.709229,"median":-0.677388,"eighty":-0.449628,"marketCap":6754621},{"date":"2026-02-13","current":-4.059663,"twenty":-2.735532,"median":-0.67969,"eighty":-0.452079,"marketCap":4981207},{"date":"2026-02-20","current":-4.229702,"twenty":-2.751093,"median":-0.699132,"eighty":-0.452121,"marketCap":5189844},{"date":"2026-02-27","current":-4.739817,"twenty":-2.822333,"median":-0.703542,"eighty":-0.455226,"marketCap":5815755},{"date":"2026-03-06","current":-3.995899,"twenty":-2.859535,"median":-0.709234,"eighty":-0.460321,"marketCap":4902968},{"date":"2026-03-13","current":-3.95339,"twenty":-2.8802,"median":-0.734703,"eighty":-0.462764,"marketCap":4850809},{"date":"2026-03-20","current":-3.783351,"twenty":-2.935436,"median":-0.742051,"eighty":-0.465065,"marketCap":4642172},{"date":"2026-03-27","current":-3.592058,"twenty":-2.957411,"median":-0.745283,"eighty":-0.466535,"marketCap":4407455},{"date":"2026-04-02","current":-3.443275,"twenty":-2.966676,"median":-0.748981,"eighty":-0.468035,"marketCap":4224898},{"date":"2026-04-10","current":-3.251981,"twenty":-2.98839,"median":-0.773888,"eighty":-0.469663,"marketCap":3990181},{"date":"2026-04-17","current":-3.188218,"twenty":-3.002868,"median":-0.835162,"eighty":-0.470275,"marketCap":3911943},{"date":"2026-04-24","current":-3.491351,"twenty":-3.043091,"median":-0.855457,"eighty":-0.470406,"marketCap":4283888},{"date":"2026-05-01","current":-3.3734,"twenty":-3.069773,"median":-0.896975,"eighty":-0.471615,"marketCap":4139162},{"date":"2026-05-08","current":-3.326219,"twenty":-3.095886,"median":-0.916058,"eighty":-0.472699,"marketCap":4081271},{"date":"2026-05-15","current":-3.113908,"twenty":-3.125638,"median":-0.932486,"eighty":-0.473641,"marketCap":3820765},{"date":"2026-05-22","current":-3.161088,"twenty":-3.125638,"median":-0.940616,"eighty":-0.474733,"marketCap":3878655},{"date":"2026-05-29","current":-3.090317,"twenty":-3.131502,"median":-0.974707,"eighty":-0.476203,"marketCap":3791819},{"date":"2026-06-05","current":-3.184678,"twenty":-3.131502,"median":-1.002727,"eighty":-0.479441,"marketCap":3907600},{"date":"2026-06-12","current":-2.736465,"twenty":-3.109856,"median":-1.315277,"eighty":-0.483319,"marketCap":3357642},{"date":"2026-06-18","current":-2.665694,"twenty":-3.101147,"median":-1.483805,"eighty":-0.485582,"marketCap":3270806},{"date":"2026-06-26","current":-2.524152,"twenty":-3.090625,"median":-1.530827,"eighty":-0.48612,"marketCap":3097135},{"date":"2026-07-02","current":-2.500562,"twenty":-3.090625,"median":-1.536052,"eighty":-0.486339,"marketCap":3068190},{"date":"2026-07-10","current":-1.890047,"twenty":-3.090317,"median":-1.603972,"eighty":-0.486669,"marketCap":2319088},{"date":"2026-07-17","current":-0.154877,"twenty":-3.090317,"median":-1.606271,"eighty":-0.486339,"marketCap":2143961},{"date":"2026-07-24","current":-0.113583,"twenty":-3.090317,"median":-1.536052,"eighty":-0.477807,"marketCap":1572331},{"date":"2026-07-31","current":-0.097429,"twenty":-3.088325,"median":-1.536052,"eighty":-0.472802,"marketCap":1348711},{"date":"2026-08-07","current":-0.083269,"twenty":-3.08312,"median":-1.499479,"eighty":-0.469926,"marketCap":1152694},{"date":"2026-08-14","current":-0.092917,"twenty":-3.06977,"median":-1.315277,"eighty":-0.462764,"marketCap":1146404},{"date":"2026-08-21","current":-0.334012,"twenty":-3.066727,"median":-1.002727,"eighty":-0.451589,"marketCap":4121044}],"updateTime":1787562178329},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VIVS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651846850","title":"Vivosim Forecasts Fy2027 Revenue Growth of 500%+","url":"https://stock-news.laohu8.com/highlight/detail?id=2651846850","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651846850?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:05","pubTimestamp":1784117143,"startTime":"0","endTime":"0","summary":"VivoSim forecasts FY2027 revenue growth of 500%+VivoSim forecast FY2027 revenue growth of more than 500%, citing rising demand for its NAM-based contract research services from drugmakers.Guidance fol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL5pdMkk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIVS","IE00BN0W2V16.EUR","IE00BKPKM429.USD","SG9999014021.USD","IE00BGHQF748.EUR","LU2095319765.USD","BK4585","NDAQ","SG9999014013.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","BCDF","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","BK4588","LU2210150020.SGD","BK4139","LU0314104364.USD","SG9999014039.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651685484","title":"Vivosim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That it Expects Revenue Growth of 500%+ in Fy2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2651685484","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651685484?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:05","pubTimestamp":1784117100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUABNQY1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VIVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651468517","title":"Vivosim Labs - Eligible for up to $45 Mln in Additional Milestone Payments from Eli Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2651468517","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651468517?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:05","pubTimestamp":1784117100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUABNQY1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0256863811.USD","IE00BFSS8Q28.SGD","LU1232071149.USD","LU2237443465.HKD","LU2462591350.SGD","LU1917777945.USD","BK4516","LU1093756168.USD","LU2108987350.USD","IE00BK4W5M84.HKD","LU0889565916.HKD","LU1366192091.USD","LU0820561909.HKD","LU1064131342.USD","LU1983299246.USD","LU1280957306.USD","IE0005OL40V9.USD","LU2089984988.USD","LU0417517546.SGD","LU0158827948.USD","LU1127390331.HKD","LU2237443382.USD","LU2552382132.HKD","LU0316494557.USD","LU0353189680.USD","LU1069344957.HKD","LU2360106947.USD","LU0198837287.USD","SG9999017495.SGD","LU2471134952.CNY","LU1548497426.USD","LU0823434740.USD","LU1323610961.USD","LU1623119135.USD","LU2552382058.USD","MEDX","IE00BJT1NW94.SGD","RXL","LU2111349929.HKD","LU0471298777.SGD","MEDI","LU0122379950.USD","LU0882574139.USD","LU0323591593.USD","LU2271345857.HKD","VHT","LU2456880835.USD","LU0456855351.SGD","LU1814569148.SGD","LU2023251221.USD","IE00BJJMRY28.SGD","LU0689472784.USD","LU2089284900.SGD","LU2168564065.EUR","LU0320765059.SGD","LU0210536198.USD","SGXZ31699556.SGD","LU0708995401.HKD","GB00BDT5M118.USD","LU0354030438.USD","LU0345770993.USD","LU0345770308.USD","LU1267930730.SGD","LU1629891620.HKD","LU2028103732.USD","LU2361044865.SGD","LU0943347566.SGD","LU1145028129.USD","LU0820562030.AUD","LU1868836914.USD","SG9999014880.SGD","IE00BKPKM429.USD","IE00BJJMRZ35.SGD","LU2461242641.AUD","LU0354030511.USD","LU1061106388.HKD","LU2213496289.HKD","LU2756315318.SGD","LU2087625088.SGD","LU2237443549.SGD","LU0096364046.USD","XLV","LU0289739699.SGD","LU1291159041.SGD","LU0683600562.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0266013472.USD","LU0238689110.USD","LU1988902786.USD","LU2168564149.EUR","IE0004445239.USD","LU1057294990.SGD","ELIS","SG9999018865.SGD","SG9999014906.USD","LU0823434583.USD","LU0471298694.HKD","LU2063271972.USD","LU1974910355.USD","SG9999015978.USD","LU1712237335.SGD","HRTS","LU2471134879.HKD","LU1989771016.USD","PJP","THNR","LU2746668461.USD","LU0256863902.USD","IE00B1XK9C88.USD","LU0106261372.USD","LU0820561818.USD","LLYX","LU2237443895.HKD","IE00B2B36J28.USD","LU0640476718.USD","LU0882574055.USD","LU0058720904.USD","LU2491050154.USD","LU2750360641.GBP","LU2756315664.SGD","LU1868837136.USD","IE00BKDWB100.SGD","SG9999013999.USD","IE00BJLML261.HKD","LU1093756325.SGD","SG9999014914.USD","LU0061475181.USD","IHE","LU1035775433.USD","LU2168564222.USD","LLII","IE00B7KXQ091.USD","BK4533","IE00BN29S564.USD","LU2361044949.HKD","LU2357305700.SGD","IE00BWXC8680.SGD","LU2491049909.HKD","SG9999001176.SGD","CURE","IE00BJJMRX11.SGD","LU2552382215.SGD","LU2265009873.SGD","LLY","SGXZ57979304.SGD","LU2750360997.AUD","LU1868836757.USD","LU2236285917.USD","LU0225283273.USD","LU0823416689.USD","LU2491050071.SGD","PPH","LU0114720955.EUR","LU2168563687.JPY","LU2089283258.USD","LU2462157665.USD","LU2237443978.SGD","BK4139","LU1023059063.AUD","LU1720051108.HKD","SG9999015952.SGD","OZEM","SG9999014898.SGD","LU0203201768.USD","LU0097036916.USD","VIVS","LU0203202063.USD","LU0158827781.USD","IE0009355771.USD","LU0094547139.USD","LU2471134796.USD","IE0004445015.USD","LU0964807845.USD","LU1868837300.USD","BK4585","BK4588","GDOC","LU1804176565.USD","LU2023250504.SGD","AGNG","LU2237443622.USD","IE00BK4W5L77.USD","LU2324357040.USD","LU2361045086.USD","LU2106854487.HKD","FTXH","LU2168564495.EUR","LU0174119429.USD","LU2211815571.USD","SGXZ51526630.SGD","BK4007","LU0006306889.USD","CANC","LU2417539215.USD","ELIL","IXJ","LU2896262040.SGD","LU0786609619.USD","LU0432979614.USD","JDOC","FHLC","IE00BFSS7M15.SGD","LU0079474960.USD","IE0002141913.USD","BK4534","LU0109391861.USD","LU0787776722.HKD","IE00B4JS1V06.HKD","LU2237438978.USD","BK4599","LU1868836591.USD","IE00B1BXHZ80.USD","LU0320765992.SGD","IE0001KFT4U8.USD","LU1720051017.SGD","SG9999001176.USD","LU1551013425.SGD","LU2468319806.SGD","BK4581","SG9999015986.USD","SGXZ81514606.USD","LU0672654240.SGD","IE00B775H168.HKD","LU1551013342.USD","LU0133085943.USD","LU2602419157.SGD","SGXZ99366536.SGD","LLYZ","LU0466842654.USD","LU0109394709.USD","LU2471134523.USD","LU0353189763.USD","LU0385154629.USD","ILDR","LU2112291526.USD","SG9999015945.SGD","SG9999018857.SGD","IYH","LU0234572021.USD","LU2023250330.USD","WDNA","LU2264538146.SGD","LU2746668974.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651463887","title":"VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2651463887","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651463887?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:05","pubTimestamp":1784117100,"startTime":"0","endTime":"0","summary":"SAN DIEGO, July  15, 2026  (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models f","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/15/3327689/37000/en/VivoSim-Receives-5M-Milestone-Payment-from-Eli-Lilly-Provides-Guidance-That-It-Expects-Revenue-Growth-of-500-in-FY2027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651481940","title":"Vivosim Labs FY26 Other Income Swings to USD 2.35 Million Expense; Revenue Rises 10% to USD 131,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2651481940","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651481940?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:51","pubTimestamp":1784062288,"startTime":"0","endTime":"0","summary":"VivoSim Labs FY26 other income swings to USD 2.35 million expense; revenue rises 10% to USD 131,000VivoSim Labs posted royalty revenue of USD 131,000, up 10% year over year, with product revenue at no","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL1Qp89w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VIVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647044433","title":"Vivosim Labs Delays Annual Report Filing, Targets July 14 Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2647044433","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647044433?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:06","pubTimestamp":1782763568,"startTime":"0","endTime":"0","summary":"VivoSim Labs delays annual report filing, targets July 14 releaseVivoSim Labs filed a Form NT 10-K, delaying its annual report for the fiscal year ended March 31, 2026.The filing missed the June 29, 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL9tx9k4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VIVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647379731","title":"Vivosim Reports >90% Sensitivity in Liver Toxicity Prediction Study at ESTIV 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647379731","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647379731?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:05","pubTimestamp":1782734717,"startTime":"0","endTime":"0","summary":"VivoSim reports >90% sensitivity in liver toxicity prediction study at ESTIV 2026VivoSim announced new preclinical data on its AI-enabled liver and GI toxicity platforms, slated for presentation at ES","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL475WbZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014021.USD","SG9999014013.SGD","LU2210149790.SGD","BK4585","BK4139","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","NDAQ","IE00BN0W2W23.USD","SG9999014039.USD","LU2210150020.SGD","VIVS","BK4588","IE00B3QW5Z07.USD","LU0314104364.USD","LU2095319765.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644798895","title":"Top News Today: Stocks Mixed Amid Tech Weakness, Oil Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2644798895","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644798895?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:44","pubTimestamp":1781642640,"startTime":"0","endTime":"0","summary":"TREASURYS: Treasury yields fell ahead of the Fed's policy decision.COMMODITIES: Oil tumbled, with U.S.-traded crude futures plunging nearly 6% and settling below $80 a barrel for the first time since March. Traders anticipated a rapid reopening of the Strait of Hormuz.SpaceX's $60 Billion Deal to Buy Cursor Gives It More AI Coding Power. SpaceX said it would buy Cursor parent Anysphere for $60 billion, striking a massive deal for an autonomous coding agent that could help the company catch up with its AI rivals after its blockbuster IPO.Prices paid for fuel imports climbed by 12.5% in May, after rising by 18.6% in April. On nonpetroleum imports, prices grew by 0.8% last month, versus April's 0.6% increase.That yielded an overall increase in import prices of 1.9%, versus","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFSS7M15.SGD","LU0175139822.USD","LU0208291251.USD","LU1599440770.SGD","IE00BN29S564.USD","IE00BKVL7J92.USD","KMX","SG9999018865.SGD","IE00BJJMRY28.SGD","SG9999004303.SGD","LU1983260115.SGD","SWBI","BK4533","BK4145","VIVS","PGR","IE0004445239.USD","BK4588","RR","LU0772969993.USD","SSKN","BK4161","SG9999014914.USD","IE00B7KXQ091.USD","LU1509826696.USD","SGXZ31699556.SGD","BK4082","LU0731783048.USD","LU1430594728.SGD","LU1035773651.USD","BK4190","BK4532","SG9999017495.SGD","BK4108","LU0742537680.HKD","LVO","BK4107","SG9999011175.SGD","JBL","BK4585","LU1861215975.USD","IE0005OL40V9.USD","IE00BFSS8Q28.SGD","LU1366192091.USD","LU1069347547.HKD","LU1861220033.SGD","LU0170899867.USD","LU1585245621.USD","LU2087625088.SGD","LU0289960550.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630043953","title":"VivoSim AI model predicts drug diarrhea risk with 96% accuracy using human intestinal tissues","url":"https://stock-news.laohu8.com/highlight/detail?id=2630043953","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630043953?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:19","pubTimestamp":1777378756,"startTime":"0","endTime":"0","summary":"VivoSim Labs on April 28, 2026 launched an AI prediction tool that uses its NAMkind human ileum and colon models to assess whether drug compounds may cause diarrhea in patients without animal testing.Model trained on dozens of compounds reached 96% predictive accuracy using 3D assay results from NAMkind intestinal tissues.Platform, branded VitroSense, ingests multiple intestinal assay endpoints to generate an overall diarrhea-risk readout for novel client compounds.VivoSim positioned tool as a screen for oncology programs, citing dose-limiting gastrointestinal toxicity risk in cancer drugs.Company also highlighted use in antibody-drug conjugate testing, including sensitivity to differences between antibody, payload, or full ADC effects on intestinal epithelium.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL3mLj90:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","VIVS","NDAQ","IE00BN0W2W23.USD","SG9999014039.USD","LU0314104364.USD","SG9999014013.SGD","BK4139","SG9999014021.USD","SG9999014005.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624664855","title":"VivoSim prices up to $4 million best-efforts public offering at $1.14 a share","url":"https://stock-news.laohu8.com/highlight/detail?id=2624664855","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624664855?lang=en_us&edition=fundamental","pubTime":"2026-04-04 04:06","pubTimestamp":1775246770,"startTime":"0","endTime":"0","summary":"VivoSim Labs priced a best-efforts public offering of up to USD 4 million, with USD 3 million funded at an initial closing.Initial closing set for April 1, 2026, subject to customary closing conditions.Offering priced at USD 1.140 per common share, with pre-funded warrants offered in lieu of common stock.Deal includes common warrants exercisable at USD 1.710 per share, expiring five years from issuance.Second closing targets additional USD 1 million on day 30, subject to conditions tied to minimum closing price and average trading volume.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VivoSim Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval syste","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL6XvFHz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VIVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624051373","title":"BRIEF-Vivosim Announces Pricing Of Up To A $4 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2624051373","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624051373?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:19","pubTimestamp":1775045985,"startTime":"0","endTime":"0","summary":"BRIEF-Vivosim Announces Pricing Of Up To A $4 Million Public OfferingApril 1 (Reuters) - VivoSim Labs Inc VIVS.O:VIVOSIM ANNOUNCES PRICING OF UP TO A $4 MILLION PUBLIC OFFERINGSource text: ID:nGNX8DL65vFurther company coverage: VIVS.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nTUAR442L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VIVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624513988","title":"VivoSim Labs prices up to $4 million best-efforts public offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2624513988","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624513988?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:06","pubTimestamp":1775045196,"startTime":"0","endTime":"0","summary":"VivoSim Labs priced a best-efforts public offering of up to USD 4 million.Initial closing expected April 1, 2026 with USD 3 million funded at USD 1.14 per share or USD 1.139 per pre-funded warrant.Offering includes common warrants exercisable at USD 1.71 per share with a five-year term.Second closing targets USD 1 million on day 30, subject to conditions including minimum closing price and average trading volume.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL9gTwDJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","BK4588","VIVS","SG9999014013.SGD","BK4112","LU2095319765.USD","SG9999014005.SGD","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BN0W2V16.EUR","BK4585","IE00BGHQF748.EUR","IE00BN0W2W23.USD","LU2210149790.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624351365","title":"Vivosim Announces Pricing of up to a $4 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2624351365","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624351365?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:05","pubTimestamp":1775045100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nTUAR442L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VIVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621603064","title":"VivoSim validates NAMkind liver and intestine models for predicting ADC toxicity profiles","url":"https://stock-news.laohu8.com/highlight/detail?id=2621603064","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621603064?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:06","pubTimestamp":1774353968,"startTime":"0","endTime":"0","summary":"VivoSim announced at the Society of Toxicology meeting in San Diego that its NAMkind liver and NAMkind Intestine models were validated for predicting toxicity and side effect profiles of antibody drug conjugates.Testing in the NAMkind liver model showed toxicity signals for gemtuzumab ozogomicin and no liver toxicity signal for enfortumab vedotin.Results also showed differential toxicity between trastuzumab emtansine and trastuzumab deruxtecan that the company said was comparable to clinical outcomes.NAMkind intestine model testing was reported to detect differential effects on epithelium and permeability endpoints across ADC, antibody-only, and payload-only compounds.VivoSim said NAMkind liver and small intestine toxicology services are available in the US and Europe, and through distributors in Korea and China.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL6RlGP5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4585","NDAQ","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","VIVS","LU2210150020.SGD","LU0314104364.USD","SG9999014039.USD","SG9999014013.SGD","BK4112","LU2210149790.SGD","BK4588","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4139","IE00B64PRP62.GBP","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616323469","title":"VivoSim appoints Arumugham Raghunathan as VP, global sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2616323469","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616323469?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:34","pubTimestamp":1772544884,"startTime":"0","endTime":"0","summary":"VivoSim (VIVS) Labs announced the appointment of Dr. Arumugham Raghunathan, PhD as Vice President of Global Sales. Based in the Greater Boston area...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vivosim-appoints-arumugham-raghunathan-as-vp-global-sales-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vivosim-appoints-arumugham-raghunathan-as-vp-global-sales-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VIVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616286003","title":"BRIEF-Vivosim Appoints Arumugham (Ragoo) Raghunathan As Vice President Of Global Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2616286003","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616286003?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:12","pubTimestamp":1772543537,"startTime":"0","endTime":"0","summary":"BRIEF-Vivosim Appoints Arumugham (Ragoo) Raghunathan As Vice President Of Global SalesMarch 3 (Reuters) - VivoSim Labs Inc VIVS.O:VIVOSIM APPOINTS ARUMUGHAM (RAGOO) RAGHUNATHAN AS VICE PRESIDENT OF GL","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUA1ZGMCH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VIVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616332839","title":"VivoSim Labs Names Arumugham Raghunathan VP of Global Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332839","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616332839?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:05","pubTimestamp":1772543114,"startTime":"0","endTime":"0","summary":"VivoSim Labs Inc. appointed Dr. Arumugham  Raghunathan, PhD as Vice President of Global Sales. Based in the Greater Boston area, he will lead global commercial expansion and strategic partnerships, with a focus on VivoSim’s liver and gastrointestinal toxicity solutions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL7tSzkJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014005.SGD","IE00B3QW5Z07.USD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210149790.SGD","LU0314104364.USD","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014039.USD","BK4585","LU2210150020.SGD","BK4139","BK4112","VIVS","SG9999014021.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616328390","title":"Vivosim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2616328390","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616328390?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:05","pubTimestamp":1772543100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUA1ZGMCH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VIVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616283323","title":"Press Release: VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2616283323","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616283323?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:05","pubTimestamp":1772543100,"startTime":"0","endTime":"0","summary":"SAN DIEGO, March 03, 2026  -- VivoSim Labs, Inc.  , a provider of next-generation New Approach Methodologies  for preclinical safety, today announced the appointment of Dr. Arumugham  Raghunathan, PhD as Vice President of Global Sales. Based in the Greater Boston area, Dr. Raghunathan will lead commercial expansion and secure strategic partnerships with biopharma innovators, established pharmaceutical companies, CROs/CDMOs, and research institutions. His focus will be on delivering VivoSim's liver and gastrointestinal  toxicity solutions for earlier de-risking of drug candidates and clearer feasibility decisions throughout the development process.\"Ragoo builds and strengthens relationships through scientific rigor and a relentless emphasis on outcomes,\" said Tony Lialin, Chief Commercial Officer of VivoSim. \"He is the kind of leader customers instantly trust and recognize as a true long-term partner. He understands how discovery, DMPK, and safety teams operate under real-world timeline","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4588","VIVS","03160","BK4555","BK4585","BK4604","BK4139","TM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":39,"code":"91000000","status":"200"}]}}